Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Abbott - The Real Truth

A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?

Abbott Laboratories' recent stock price dip contrasts with its strong Medical Devices division, creating a noteworthy opportunity for dividend investors.

MarketBeat

Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?

Johnson & Johnson offers scale and stability, but Abbott’s cheaper valuation, higher yield, and stronger upside make it the more attractive pick now.

Barchart

Buy the Dip: These 3 Over-$100 Stocks Just Hit New 52-Week Lows

Among the 128 new 52-week lows on the NYSE on Tuesday, there were five with share prices of $100 or higher. Not all of them are worth buying on the dip. We rate three that could be.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

This Dividend King Is Down 26%. When Will It Bounce Back?

Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion, the Dividend King seems discounted, but the question is, can it rebound?

Barchart

Abbott Earnings Preview: What to Expect

Abbott is expected to announce its first-quarter results soon, and analysts are projecting single-digit EPS growth.

Barchart

3 High Dividend Growth Kings for Generations of Income That Are Still Rated ‘Buy’

These 3 Dividend Kings combine steady businesses, rising dividends, and solid upside potential for long-term income investors.

Barchart

This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip?

This Dividend King is suddenly on sale. Should you buy the dip?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths

Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce falsely low glucose readings

The Independent UK

What to Know About Recent FDA Alerts Involving Glucose Monitors in 2026

For millions living with diabetes, a continuous glucose monitor (CGM) is more than technology. It is a lifeline that provides safety in an unpredictable world. These devices allow you to sleep without fear and eat without complex math. However, high-level FDA alerts can vanish that sense of security instantly. False…

Budget and the Bees

Coworkers of different generations mentor each other to reduce workplace misunderstandings

With at least five generations participating in the U.S. workforce, coworkers can at times feel like they speak different languages

The Independent UK

New implant for heart failure patients to be rolled out across the NHS

The British Heart Foundation estimates that more than a million people in the UK are living with heart failure

The Independent UK

Do Wall Street Analysts Like Abbott Laboratories Stock?

While Abbott Laboratories has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

Barchart

Is Abbott’s January Pullback a Good Time to Buy?

Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its business and driving cash flow.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Cinemablend

How Authentic Was Abbott Elementary In Relocating The Cast To An Abandoned Mall? Janelle James Opened Up About ‘Lots Of Smells’

At least the animatronic Ben Franklin head is dead!

MarketBeat

2 Healthcare Names That Could Get a Big Boost From Earnings

Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.

Fortune

Fortune 500 exec: College grads aren't ready for today's jobs

There's a missing link between college and career.

Cinemablend

With Abbott Elementary Nominated For Major Awards, The Stars Opened Up About Representing Traditional Sitcoms Against Streaming Competition

Will Abbott Elementary score in the awards circuit this year?

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

This Dividend Stock Just Scored an FDA Win. Should You Buy Shares Now?

Abbott’s latest regulatory progress supports its durable growth narrative. Is now the right time to revisit ABT shares?

MarketBeat

Broadcom Just Raised Its Dividend—But It’s Not the Only One Signaling Strength

Broadcom, Abbott, and Nordic American raised dividends, offering strong yields and long-term upside despite market volatility and sector headwinds.

Cinemablend

Abbott Elementary's Mid-Season Finale Featured Its Craziest Plot Twist, And I Can't Stop Thinking About The Silly Repercussions It Could Have

I cannot believe this really happened!

Benzinga

FDA Warns Against Abbott Glucose Monitor Sensors After Reports Of Over 700 Injuries, 7 Deaths

The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott Laboratories’ (NYSE:ABT) Diabetes Care, after the company linked the devices to seven deaths and hundreds of serious injuries.

Euronews

Faulty glucose monitors linked to 7 deaths and more than 700 injuries worldwide. Here’s what we know

The sensors provide real-time measurements of sugar levels in the blood, sending that data wirelessly to a device or phone.

The Independent UK

Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns

The U.S. Food and Drug Administration warned people to stop using certain types of glucose monitor sensors that were linked to seven deaths

The Independent UK

7 deaths linked to faulty glucose monitors put in people’s arms, FDA says

About three million devices are affected, though many may be expired or already used

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.